GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » Cash-to-Debt

Otsuka Holdings Co (Otsuka Holdings Co) Cash-to-Debt : 2.47 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Otsuka Holdings Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Otsuka Holdings Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 2.47.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Otsuka Holdings Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Otsuka Holdings Co's Cash-to-Debt or its related term are showing as below:

OTSKY' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.51   Med: 1.95   Max: 7.58
Current: 2.47

During the past 13 years, Otsuka Holdings Co's highest Cash to Debt Ratio was 7.58. The lowest was 1.51. And the median was 1.95.

OTSKY's Cash-to-Debt is ranked better than
63.84% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs OTSKY: 2.47

Otsuka Holdings Co Cash-to-Debt Historical Data

The historical data trend for Otsuka Holdings Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Otsuka Holdings Co Cash-to-Debt Chart

Otsuka Holdings Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 1.78 2.03 2.52 2.47

Otsuka Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 2.65 2.77 2.90 2.47

Competitive Comparison of Otsuka Holdings Co's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otsuka Holdings Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's Cash-to-Debt falls into.


Otsuka Holdings Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Otsuka Holdings Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=3676.882 / (613.079 + 874.522)
=2.47

Otsuka Holdings Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=3676.882 / (613.079 + 874.522)
=2.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co  (OTCPK:OTSKY) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Otsuka Holdings Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Otsuka Holdings Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Otsuka Holdings Co (Otsuka Holdings Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » Cash-to-Debt
Comparable Companies
TSE:4503 TSE:4151 TSE:4528 TSE:4536 TSE:4552 TSE:4882 TSE:4519 TSE:4568 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD
Traded in Other Exchanges
OTSKF:USA 4578:Japan OS1:Germany
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Website
http://www.otsuka.com/jp
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.